# Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease

> **NCT01694732** · PHASE3 · COMPLETED · sponsor: **University Hospital, Brest** · enrollment: 83 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease
- COPD Exacerbation
- Smoking

## Interventions

- **DRUG:** Varenicline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01694732
- **Lead sponsor:** University Hospital, Brest
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2015-11
- **Final completion:** 2015-11
- **Target enrollment:** 83 (ACTUAL)
- **Last updated:** 2016-02-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01694732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01694732, "Efficacy of Varenicline on Smoking Cessation at the Acute Phase of an Exacerbation of Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01694732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*